Sirion

Halia Therapeutics, based in Lehi, UT, takes an innovative approach to medical research by focusing on genetic resilience rather than traditional disease models. By studying individuals who remain healthy despite high-risk genetic mutations, the company aims to uncover insights that inform the development of new, more effective therapies that align with the body's natural protective mechanisms. The company's proprietary GENMOR platform analyzes extensive familial and health data to identify biological factors that confer disease resistance. By leveraging advanced artificial intelligence, Halia accelerates drug discovery, directing attention to viable therapeutic targets inspired by real-world human experiences, ultimately redefining the landscape of preventative medicine. Generated from the website